CAMP4 THERAPEUTICS CORPORATION (CAMP) is a Healthcare · Biotechnology company listed on NASDAQ. Price $4.11 (+1.99%), Market cap $0.22B, 52-week low–high $1.35 ~ $7.13.
Camp4 Therapeutics Corporation, a clinical-stage biopharmaceutical company, discovers and develops RNA-based therapeutics to treat a range of genetic diseases. Its lead product candidate is CMP-001, which is in a Phase 1/2 clinical trial for the treatment of urea cycle disorders. The company also develops CMP-002 for the treatment of SYNGAP1-related disorders. Camp4 Therapeutics Corporation was formerly known as Marauder Therapeutics, Inc. and changed its name to Camp4 Therapeutics Corporation in March 2018. The company was incorporated in 2015 and is headquartered in Cambridge, Massachusetts.
Financial statements, price targets, institutional (13F) holdings and related news for CAMP4 THERAPEUTICS CORPORATION are updated in real time on BlackAll Trade.
CAMP4 THERAPEUTICS CORPORATION trades at $4.11 (+1.99%). Real-time quotes and charts are available on BlackAll Trade.
CAMP4 THERAPEUTICS CORPORATION has a market cap of about $0.22B.
Camp4 Therapeutics Corporation, a clinical-stage biopharmaceutical company, discovers and develops RNA-based therapeutics to treat a range of genetic diseases. Its lead product candidate is CMP-001, w